Let’s make a deal, Merck (NYSE: MRK) to acquire Cidara for $9.2 billion
Let’s make a deal, Merck (NYSE: MRK) to acquire Cidara for $9.2 billion Merck (NYSE: MRK) announced it will acquire Cidara Therapeutics (CDTX) for $221.50 per share in cash, valuing the transaction at approximately $9.2 billion. The acquisition centers on...
OOB Token Debuts on Kraken Following VCIG’s (NASDAQ: VCIG) US$100 Million Acquisition
OOB Token Debuts on Kraken Following VCIG’s (NASDAQ: VCIG) US$100 Million Acquisition VCI Global’s Treasury Management Framework Positions OOB as a Next-Generation Utility Token Bridging Real-World Payments and Institutional TrustVCI Global Limited (NASDAQ: VCIG)...
IBM unveils quantum Nighthawk processor targeting advantage by 2026
IBM unveils quantum Nighthawk processor targeting advantage by 2026 IBM (NYSE: IBM) announced new quantum computing developments at its Quantum Developer Conference, including the IBM Quantum Nighthawk processor and progress toward fault-tolerant quantum computing by...
